Pune, India -- (SBWire) -- 01/29/2018 --The Aptamers Market accounted to USD 126.80 million in 2016 growing at a CAGR of 18.23% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Also the Global Aptamers Market By Type (DNA-Based, RNA-Based, XNA-Based), By Application (Diagnostics, Therapeutics Development, R&D), By Technology (SELEX), By End User (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, CRO), By Geography – Industry Trends and Forecast to 2024.
Aptamers are single-stranded DNA or RNA (ssDNA or ssRNA) molecules. Aptamers are the oligonucleotide or peptide molecules that bind to a specific target molecule. It assumes to have variety of shapes due to their tendency to form helices and single-stranded loops. There are many advantages of these small molecules in comparison to the antibodies.
Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-aptamers-market
Major Market Drivers and Restraints:
Increased R&D investments in biotechnology and pharmaceutical sectors
Low cost of aptamers
High efficiency of aptamers to bind large molecules as compared to antibodies
Technological advancements
Patent Expiration of SELEX
Low market acceptance
Lack of trained professionals
Market Segmentation: Global Aptamers Market
The global aptamers market is segmented by type into DNA-based aptamers, RNA-based aptamers and XNA-based aptamers.
On the basis of application the market is segmented into diagnostics, therapeutics development, research and development (R&D) and others.
On the basis of technology the market is segmented into systemic evolution of ligands by exponential enrichment (SELEX) and others.
By End User the market is segmented into academic and government research institutes, biotechnology & pharmaceutical companies and contract research organizations.
On the basis of geography, aptamers market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Have Any Query? Ask Ours Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-aptamers-market
Competitive Analysis: Global Aptamers Market
The aptamers market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of aptamers market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Global Aptamers Market
Some of the major players operating in aptamers market are Aptamer Sciences, Inc., AMBiotech, Aptagen, LLC., Aptamer Group, Aptus Biotech, Base Pair Biotechnologies, Cambio, NeoVentures Biotechnology Inc., SOMALOGIC, INC., TriLink BioTechnologies, LLC, Vivonics Inc., NOXXON Pharma, Ophthotech Corporation, 2bind, NOVAPTECH, Donovan, LLC, ATDBio Ltd., AuramerBio, Barrick Lab, Creative Biogene, AMS Biotechnology (Europe) Limited, IBA GmbH and Kaneka Corporation among others.
Read More Information of This Report…Follow Link @ http://databridgemarketresearch.com/reports/global-aptamers-market/
Aptamers Market 2017: Industry Research, Demand, Growth, Global Analysis and Forecast 2024
Global Aptamers Market By Type (DNA-Based, RNA-Based, XNA-Based), By Application (Diagnostics, Therapeutics Development, R&D), By Technology (SELEX), By End User (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, CRO), By Geography – Industry Trends and Forecast to 2024.